Cover Image

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	James M. Stevenson, D. Max Smith, Sony Tuteja, Jai N. Patel
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
by: Teresa T. Ho, et al.
Published: (2025)

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges
by: D. Max Smith, et al.
Published: (2025)

Pharmacogenomic Prescribing Guidelines: Are They Always Useful?
by: Magnus Ingelman‐Sundberg
Published: (2024)

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations
by: Kaio Evandro Cardoso Aguiar, et al.
Published: (2026)

Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans
by: Sihan Chen, et al.
Published: (2026)

Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
by: Ian T.T. Liu, et al.
Published: (2026)

A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence‐Based Pharmacogenomic Information
by: Loren Saulsberry, et al.
Published: (2025)

Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module
by: Bradley T. Hall, et al.
Published: (2025)

Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data
by: Kaisa Litonius, et al.
Published: (2024)

Long‐Read Sequencing Enhances Pharmacogenomic Profiling by Resolving Complex Haplotypes, Novel Star Alleles, and Structural Variants
by: Sumudu Rangika Samarasinghe, et al.
Published: (2025)

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans
by: Guang Yang, et al.
Published: (2025)

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
by: Pablo Lapuerta, et al.
Published: (2024)

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program
by: Catherine Chanfreau‐Coffinier, et al.
Published: (2025)

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned
by: Tyler Shugg, et al.
Published: (2024)

Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends
by: Jason Boer, et al.
Published: (2026)

Evolving Standards: Good Clinical Practice Insights from US FDA , MHRA UK , and Health Canada
by: Cheryl Grandinetti, et al.
Published: (2025)

Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor
by: Manthena V. S. Varma, et al.
Published: (2025)

Best Practices for Pharmacokinetic Studies of New Chemical Entities
by: Ya‐Feng Wen, et al.
Published: (2024)

Carbon Footprint of Antibody‐Based Drugs and Biologics Using Hybrid Life Cycle Assessment
by: Sébastien Taillemite, et al.
Published: (2026)

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies
by: Sonia Zebachi, et al.
Published: (2025)

Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment
by: Raj Vuppalanchi, et al.
Published: (2024)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
by: Matthijs W. van Hoogdalem, et al.
Published: (2025)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
by: Jules M. Janssen Daalen, et al.
Published: (2024)

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data
by: Eissa A. Jafari, et al.
Published: (2025)

Low Nirmatrelvir and Ritonavir Exposure through Breastmilk: Analyzing Milk Concentrations and Infant Risk
by: Jean Dai, et al.
Published: (2024)

Impact of Regulatory Post‐Market Safety Advisories on Prescribing Practices: An Interrupted Time Series Analysis
by: Seonji Kim, et al.
Published: (2025)

From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy
by: Lisa Cuba, et al.
Published: (2024)

A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions
by: Céline K. Stäuble, et al.
Published: (2024)

A Joint Pharmacometric Model of Iohexol and Creatinine Administered through a Meat Meal to Assess GFR and Renal OCT2/MATE Activity
by: Zhendong Chen, et al.
Published: (2025)

How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians
by: Ameet Sarpatwari, et al.
Published: (2024)

Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
by: Anu Patel, et al.
Published: (2024)

Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model‐Informed Drug Development Perspective
by: Rajesh Krishna, et al.
Published: (2025)

RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome‐Wide Association Studies
by: Shailja C. Shah, et al.
Published: (2025)

Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations
by: Zhirong Yang, et al.
Published: (2024)

Comparative Safety of Long‐Acting vs. Short‐Acting Erythropoiesis‐Stimulating Agents Among Patients Undergoing Hemodialysis
by: Raj Desai, et al.
Published: (2024)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
by: Mariam A. Ahmed, et al.
Published: (2024)

Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review
by: Joseph V. Turner, et al.
Published: (2024)

Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
by: Mohamed A. Kamal, et al.
Published: (2024)

Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing
by: Ashley N. Springer, et al.
Published: (2025)

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
by: Judith Y. M. N. Derijks‐Engwegen, et al.
Published: (2024)